Actual Credits Received Related To Duplicate Billings
Alkermes·Products & Services·3 segments
| Segment | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|
| Vivitrol | $17.7M | $25.3M | $26.7M | $5.4M |
| Aristada And Aristada Initio | $7.2M | $12.1M | $13.6M | $2.8M |
| LYBALVI | — | — | — | $500K |
| Total | $17.7M | $25.3M | $26.7M | $5.4M |